Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Additional Information (Details)

v3.23.2
Financial Instruments - Additional Information (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Jun. 30, 2023
Apr. 30, 2023
Jan. 17, 2023
Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Marketable equity securities   $ 20,488     $ 18,529
Net unrealized gain   483     0
Contingent consideration liability   300     2,941
Investments in privately held entities   11,800     $ 11,800
Company X          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration liability     $ 2,700    
Contingent consideration (up to)   3,000      
Company X | Forecast          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration liability $ 300        
Company Y          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration (up to)   $ 2,600   $ 2,600